Blog Post
Unlocking the Potential to Scale Cell Therapies: Leveraging Synthetic Biology and High-Quality Teams
Proteins: Translating Structure into Function
MEC Portfolio Company Aspen Neuroscience Featured in Wall Street Journal for Parkinson’s Disease Research
Looking Ahead Series: Insights on Innovation from the MEC Council and the Brightest Minds
Medical Excellence Foundation Announces First MERIT Grant
Our Sophomore Year: A Review of 2022
Looking Ahead Series: Developing Insights from the MEC Council and the Brightest Minds
Delivery Innovation hits Gene Therapy
MERIT: Funding “Hard to Fund” Science with MERIT
Cell Therapy in CNS: Why now?